NCT00005797
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +52 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
Clinical trial condition
Thrombocythemia, Essential
Explore clinical trials studying Thrombocythemia, Essential. Study availability and eligibility vary by location and protocol.
184 public trials
31 recruiting studies
Thrombocythemia, Essential trial results
Completed
Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure
NCT02912884
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
- Locations
-
- Geneva University Hospitals Geneva, Switzerland
- Guy's Hospital London, United Kingdom
Completed
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
NCT00006083
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +94 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
NCT00054236
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +75 more
- Locations
-
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00750009
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +106 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
NCT02823184
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
- Locations
-
- Chu Angers Angers, France
- Ch de La Cöte Basque Bayonne, France
- Chu de Bordeaux Bordeaux, France
- Crlcc Bergonie Bordeaux, France
NCT01787552
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
- Locations
-
- Novartis Investigative Site Camperdown, New South Wales, Australia
- Novartis Investigative Site Woolloongabba, Queensland, Australia
- Novartis Investigative Site Leuven, Belgium
- Novartis Investigative Site Toronto, Ontario, Canada
NCT00003687
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
- McGill University Montreal, Quebec, Canada
Completed
The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase
NCT03907436
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +19 more
- Locations
-
- University of California, Irvine Irvine, California, United States
NCT00397813
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Refractory, +40 more
- Locations
-
- LDS Hospital Salt Lake City, Utah, United States
- Veterans Administration Center-Seattle Seattle, Washington, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States